Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Finch Therapeutics Group, Inc. (FNCH) had Weighted-Average Shares Outstanding (Diluted) of 1.60M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$0.11M |
|
$-74.75M |
|
-- |
|
$0.11M |
|
$83.97M |
|
$-83.86M |
|
$5.65M |
|
$-78.22M |
|
$-78.85M |
|
$-74.75M |
|
$-74.75M |
|
$-74.75M |
|
$-75.42M |
|
$-83.86M |
|
$-82.34M |
|
1.60M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
1.60M |
$-46.59 |
|
$-46.59 |
|
| Balance Sheet Financials | |
$25.85M |
|
$0.59M |
|
$29.53M |
|
$55.37M |
|
$4.08M |
|
-- |
|
$28.40M |
|
$32.49M |
|
$22.89M |
|
$22.89M |
|
$22.89M |
|
1.61M |
|
| Cash Flow Statement Financials | |
$-31.50M |
|
$1.33M |
|
$-16.16M |
|
$73.81M |
|
$27.47M |
|
$-46.33M |
|
$1.93M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.33 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-78374.77% |
|
-78374.77% |
|
-76954.20% |
|
-73098.13% |
|
-69863.55% |
|
$-30.18M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-326.64% |
|
-326.64% |
|
-135.00% |
|
-326.64% |
|
$14.25 |
|
$-18.80 |
|
$-19.63 |
|